AR054133A1 - Preparacion recubierta con azucar - Google Patents
Preparacion recubierta con azucarInfo
- Publication number
- AR054133A1 AR054133A1 ARP060102421A ARP060102421A AR054133A1 AR 054133 A1 AR054133 A1 AR 054133A1 AR P060102421 A ARP060102421 A AR P060102421A AR P060102421 A ARP060102421 A AR P060102421A AR 054133 A1 AR054133 A1 AR 054133A1
- Authority
- AR
- Argentina
- Prior art keywords
- sugar
- oxygen
- active ingredient
- preparation
- preparation according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
- A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/4035—Isoindoles, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se provee una preparacion en donde un ingrediente activo inestable al oxígeno es estabilizada por recubrimiento de una parte que contiene el ingrediente activo inestable al oxígeno con una capa de recubrimiento con azucar que contiene (1) alcohol de azucar como material base de recubrimiento con azucar y (2) un aglutinante. Reivindicacion 2: La preparacion de acuerdo con la reivindicacion 1, caracterizada porque el alcohol de azucar es uno o más de uno seleccionado entre eritritol, manitol, xilitol y sorbitol. Reivindicacion 5: La preparacion de acuerdo con la reivindicacion 1, caracterizada porque el aglutinante es goma arábiga. Reivindicacion 8: La preparacion de acuerdo con la reivindicacion 1, caracterizada porque el ingrediente activo inestable al oxígeno es (R)-5,6-dimetoxi-2-[2,2,46,7-pentametil-3-(4-metilfenil)-2,3-dihidro-1-benzofuran-5-il]isoindolina.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005171443 | 2005-06-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR054133A1 true AR054133A1 (es) | 2007-06-06 |
Family
ID=37498554
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060102421A AR054133A1 (es) | 2005-06-10 | 2006-06-09 | Preparacion recubierta con azucar |
Country Status (19)
Country | Link |
---|---|
US (1) | US20090030064A1 (es) |
EP (1) | EP1889611A1 (es) |
JP (1) | JPWO2006132360A1 (es) |
KR (1) | KR20080014014A (es) |
CN (1) | CN101193625A (es) |
AR (1) | AR054133A1 (es) |
AU (1) | AU2006256038A1 (es) |
BR (1) | BRPI0611058A2 (es) |
CA (1) | CA2610342A1 (es) |
CR (1) | CR9523A (es) |
IL (1) | IL187407A0 (es) |
MA (1) | MA29540B1 (es) |
NO (1) | NO20080175L (es) |
NZ (1) | NZ563820A (es) |
PE (1) | PE20070077A1 (es) |
RU (1) | RU2407515C2 (es) |
TW (1) | TW200716207A (es) |
WO (1) | WO2006132360A1 (es) |
ZA (1) | ZA200710333B (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2251012A4 (en) | 2008-02-11 | 2013-03-06 | Dainippon Sumitomo Pharma Co | TABLET HAVING ENHANCED ELUTING PROPERTIES |
TW201021832A (en) * | 2008-09-30 | 2010-06-16 | Astellas Pharma Inc | Pharmaceutical composition for oral administration |
TWI531584B (zh) * | 2009-09-02 | 2016-05-01 | 日本曹達股份有限公司 | 含有羥烷基纖維素之被覆劑 |
CN101804042A (zh) * | 2010-04-16 | 2010-08-18 | 山东新华制药股份有限公司 | 普拉格雷片剂的制备方法 |
US10251194B2 (en) * | 2013-06-17 | 2019-04-02 | Nxp Usa, Inc. | Efficient scheduling in asynchronous contention-based system |
FR3013186B1 (fr) * | 2013-11-19 | 2019-07-19 | Roquette Freres | Nouveaux snacks non allergenes contenant des proteines vegetales |
CN103977427A (zh) * | 2014-05-08 | 2014-08-13 | 王�琦 | 一种糖衣产气粉配方及其制备方法 |
FR3067567B1 (fr) * | 2017-06-19 | 2019-07-05 | Roquette Freres | Nouveau procede de drageification et formes solides drageifiees presentant des formes irregulieres |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3066710D1 (en) * | 1979-10-17 | 1984-03-29 | Roquette Freres | Process for hard coating with sorbitol |
JPH0816052B2 (ja) * | 1988-11-21 | 1996-02-21 | エスエス製薬株式会社 | 糖衣錠 |
JP3507211B2 (ja) * | 1995-07-13 | 2004-03-15 | 三菱化学株式会社 | 糖衣液及び糖衣錠 |
ATE261435T1 (de) * | 1998-12-04 | 2004-03-15 | Takeda Chemical Industries Ltd | Benzofuranderivate, verfahren zu ihrer herstellung und deren verwendungen |
JP2001139495A (ja) * | 1999-11-19 | 2001-05-22 | Shin Etsu Chem Co Ltd | フィルムコーティング剤及び経口固形製剤 |
AT500063A1 (de) * | 1999-11-23 | 2005-10-15 | Sandoz Ag | Beschichtete tablettenkerne |
JP2002047174A (ja) * | 2000-05-26 | 2002-02-12 | Towa Chem Ind Co Ltd | 無糖コーティング製剤及びその製造方法 |
JP2002179559A (ja) * | 2000-10-06 | 2002-06-26 | Takeda Chem Ind Ltd | 薄層糖衣錠およびその製造方法 |
JP2003113060A (ja) * | 2001-10-02 | 2003-04-18 | Lion Corp | 発泡成分含有糖衣物 |
JP4336074B2 (ja) * | 2001-11-15 | 2009-09-30 | 三菱商事フードテック株式会社 | 色調および食感が良好な硬質糖衣錠剤 |
CA2469940A1 (en) * | 2001-12-19 | 2003-06-26 | Takeda Chemical Industries, Ltd. | Solid compositions comprising compounds unstable to oxygen and method for stabilizing them |
JP4590034B2 (ja) * | 2002-01-31 | 2010-12-01 | 三菱商事フードテック株式会社 | 硬質糖衣製剤、糖衣液及び硬質糖衣製剤の製造方法 |
JP2004123578A (ja) * | 2002-09-30 | 2004-04-22 | Dainippon Ink & Chem Inc | 糖衣錠およびその製造方法 |
JP2005298373A (ja) * | 2004-04-08 | 2005-10-27 | Kyowa Hakko Kogyo Co Ltd | 吸水性アミノ酸含有糖衣錠剤 |
JP4984455B2 (ja) * | 2004-08-18 | 2012-07-25 | 日本新薬株式会社 | 二重被覆錠剤 |
-
2006
- 2006-06-07 PE PE2006000633A patent/PE20070077A1/es not_active Application Discontinuation
- 2006-06-08 TW TW095120313A patent/TW200716207A/zh unknown
- 2006-06-09 BR BRPI0611058-4A patent/BRPI0611058A2/pt not_active IP Right Cessation
- 2006-06-09 CN CNA2006800206046A patent/CN101193625A/zh active Pending
- 2006-06-09 NZ NZ563820A patent/NZ563820A/en not_active IP Right Cessation
- 2006-06-09 KR KR1020077028672A patent/KR20080014014A/ko not_active Application Discontinuation
- 2006-06-09 ZA ZA200710333A patent/ZA200710333B/xx unknown
- 2006-06-09 CA CA002610342A patent/CA2610342A1/en not_active Abandoned
- 2006-06-09 JP JP2007520182A patent/JPWO2006132360A1/ja not_active Withdrawn
- 2006-06-09 RU RU2007145426/15A patent/RU2407515C2/ru not_active IP Right Cessation
- 2006-06-09 US US11/921,731 patent/US20090030064A1/en not_active Abandoned
- 2006-06-09 WO PCT/JP2006/311618 patent/WO2006132360A1/ja active Application Filing
- 2006-06-09 AU AU2006256038A patent/AU2006256038A1/en not_active Abandoned
- 2006-06-09 AR ARP060102421A patent/AR054133A1/es not_active Application Discontinuation
- 2006-06-09 EP EP06766530A patent/EP1889611A1/en not_active Withdrawn
-
2007
- 2007-11-15 CR CR9523A patent/CR9523A/es not_active Application Discontinuation
- 2007-11-15 IL IL187407A patent/IL187407A0/en unknown
- 2007-12-10 MA MA30465A patent/MA29540B1/fr unknown
-
2008
- 2008-01-10 NO NO20080175A patent/NO20080175L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20080175L (no) | 2008-03-04 |
CA2610342A1 (en) | 2006-12-14 |
AU2006256038A1 (en) | 2006-12-14 |
IL187407A0 (en) | 2008-02-09 |
US20090030064A1 (en) | 2009-01-29 |
MA29540B1 (fr) | 2008-06-02 |
ZA200710333B (en) | 2009-03-25 |
CR9523A (es) | 2008-02-04 |
RU2407515C2 (ru) | 2010-12-27 |
RU2007145426A (ru) | 2009-06-20 |
PE20070077A1 (es) | 2007-02-07 |
CN101193625A (zh) | 2008-06-04 |
BRPI0611058A2 (pt) | 2011-02-22 |
KR20080014014A (ko) | 2008-02-13 |
EP1889611A1 (en) | 2008-02-20 |
JPWO2006132360A1 (ja) | 2009-01-08 |
NZ563820A (en) | 2010-03-26 |
WO2006132360A1 (ja) | 2006-12-14 |
TW200716207A (en) | 2007-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR054133A1 (es) | Preparacion recubierta con azucar | |
PE20081663A1 (es) | Preparacion solida que comprende alogliptin y pioglitazona | |
ES2560901T3 (es) | Preparaciones recubiertas de azúcar duro, soluciones de recubrimiento de azúcar y procedimiento para producir preparaciones recubiertas de azúcar duro | |
PE20060425A1 (es) | Formulacion de tableta revestida que comprende saxagliptina | |
AR053292A1 (es) | Un sistema de suministro para dos o mas componentes acivos como parte de una composicion comestible | |
HRP20050828A2 (en) | Uv stable transdermal therapeutic plaster | |
CL2014000187A1 (es) | Composicion de encolado que comprende una mezcla de azucares hidrogenados que comprenden mezcla de azucares hidrogenados que comprenden al menos 25 % en peso de maltitol, clculado sobre la base de la materia seca de los azucares ghidrogenados y al menos un agente de reticulacion polifuncional; producto aislante acustico o termico; y velo de fibras minerales. | |
AR058605A1 (es) | Preparacion solida | |
AR057708A1 (es) | Estructura laminar | |
BR112012014722A2 (pt) | "microcápsulas de sílica de liberação sustentada" | |
CR8428A (es) | Agente endoparasiticidas para la administracion topica | |
PE20030580A1 (es) | Composiciones farmaceuticas de glibenclamida y metformina, en capas separadas | |
AR114148A2 (es) | Composición terapéutica saborizada basada en arcilla | |
DK2083638T3 (da) | Smagsfrigivende kerner og deres anvendelse i tyggegummi | |
CY1109209T1 (el) | Μητρες ανιονικης υδρογελης με ph-εξαρτωμενη τροποιημενη αποδεσμευση ως μεταφορεις φαρμακων | |
DE602006005273D1 (de) | Pharmazeutische Zusammensetzung | |
MX2008008413A (es) | Composicion farmaceutica para el tratamiento de las enfermedades de las uñas. | |
ECSP056186A (es) | Composición farmacéutica en forma de hidrogel para administración transdérmica de sustancias activas | |
AR028525A1 (es) | Sistema terapeutico transdermal para la administracion de lerisetron | |
WO2009138608A3 (fr) | Composition stable destinee a l'assemblage demontable de substrats par collage | |
AR061634A1 (es) | Material compuesto de madera que contiene paulonia | |
CA2643014A1 (en) | Liquid-filled chewing gum composition | |
CR9839A (es) | Composicion farmaceutica fotoestable que contiene brivudina para el tratamiento de la queratitis herpetica | |
CN202810107U (zh) | 一种环保复合地板 | |
DE50211742D1 (de) | Trägermatrix mit wirkstoffbeladenen partikeln zur anwendung auf der haut oder schleimhaut |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |